Axsome Therapeutics AXSM
NASDAQ AXSM
$182.07 -2.32 (-1.26%)
At close: Oct 1, 2026 · 4:00 PM EDT

Axsome Therapeutics (AXSM) Other financing activities (2021 - 2026)

Updated

Axsome Therapeutics' Other financing activities was $2.83 million in Q2 2026, up 219.1% from $888,000 a year earlier but down 69.5% from the prior quarter.

Analysis

Axsome Therapeutics (AXSM) Other financing activities (2021 - 2026) Analysis & Trends

On a trailing twelve-month basis, Axsome Therapeutics' Other financing activities was $14.02 million through Jun 30, 2026, up 125.1% year-over-year; for FY2025, it was $7.11 million, up 79.9% from FY2024.

  • Other financing activities has now increased for four consecutive years, with a five-year compound annual growth rate of 45.2% (FY2020 to FY2025).
  • In earlier years, Other financing activities was $3.95 million in FY2024 (+115.4%), $1.84 million in FY2023 (+244.9%), $532,000 in FY2022 (+72.2%) and $309,000 in FY2021 (-72.0%).
  • Quarterly Other financing activities has moved between -$462,000 (Q4 2023) and $9.3 million (Q1 2026) over five years.
  • Compared with a year earlier, Other financing activities has increased for four straight quarters, with growth averaging 85.4% over the last seven quarters.
  • The best year-over-year quarter for Other financing activities over five years was Q2 2024 (growth of 492.9%); the worst was Q4 2022 (a decline of 80.0%).
  • Per Business Quant data, AXSM's Other financing activities in the three quarters before Q2 2026 was $9.3 million (Q1 2026), $1.04 million (Q4 2025) and $842,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Axsome Therapeutics 9.64 Bn 8.37 Bn 204.81 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.83 Mn
Mar 31, 2026 9.30 Mn
Dec 31, 2025 1.04 Mn
Sep 30, 2025 842,000.00
Jun 30, 2025 888,000.00
Mar 31, 2025 4.34 Mn
Dec 31, 2024 533,000.00
Sep 30, 2024 473,000.00
Jun 30, 2024 1.33 Mn
Mar 31, 2024 1.62 Mn
Dec 31, 2023 -462,000.00
Sep 30, 2023 856,000.00
Jun 30, 2023 224,000.00
Mar 31, 2023 1.22 Mn
Dec 31, 2022 45,000.00
Jun 30, 2022 398,000.00
Mar 31, 2022 89,000.00
Dec 31, 2021 224,990.00
API Access

Axsome Therapeutics Other financing activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-financing-activities&ticker=AXSM&period=max&api_key=YOUR_API_KEY